Brownlee, W;
Bourdette, D;
Broadley, S;
Killestein, J;
Ciccarelli, O;
(2020)
Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.
Neurology
10.1212/WNL.0000000000009507.
(In press).
![[thumbnail of Brownlee_Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic_AAM.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/text.png) |
Text
Brownlee_Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic_AAM.pdf - Accepted Version Access restricted to UCL open access staff Download (1MB) |
Abstract
The emergence of novel Coronavirus 2019 (COVID-19)1 and the subsequent pandemic present a unique challenge to Neurologists managing patients with multiple sclerosis (MS) and related neuroinflammatory disorders, such as neuromyelitis spectrum disorder (NMOSD).
| Type: | Article |
|---|---|
| Title: | Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic |
| Location: | United States |
| DOI: | 10.1212/WNL.0000000000009507 |
| Publisher version: | https://doi.org/10.1212/WNL.0000000000009507 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neuroinflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10094690 |
Archive Staff Only
 |
View Item |
